Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.10% Nasdaq Up 0.23%
Streaming
Ticker Tape: On

More On DIVISLAB.NS

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates
  • Research Reports

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Divi's Laboratories Limited (DIVISLAB.NS)

-NSE
1,324.80 Up 0.25(0.02%) Apr 17, 5:59AM EDT
Get the big picture on all your investments.
Prev Close:1,324.55
Open:1,327.15
Bid:N/A
Ask:1,324.80
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:1,313.20 - 1,338.85
52wk Range:905.25 - 1,455.00
Volume:113,622
Avg Vol (3m):175,088
Market Cap:175.85B
P/E (ttm):29.21
EPS (ttm):45.35
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in INR.

Headlines

» More Headlines for DIVISLAB.NS

Reports

  • No Reports available for DIVISLAB.NS at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):8.21
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Divi’s Laboratories Limited manufactures active pharmaceutical ingredients (API) and intermediates for generics in India. The company also offers building blocks for peptides and nucleotides; carotenoids, such as apocarotenal, betacarotene, l... View More

Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback